/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Improving the prediction of major adverse cardiovascular events in patients with hypertrophic cardiomyopathy by adding plasma SVEP1 to conventional clinical model including NT-proBNP
Event: ESC Congress 2024
Topic: Hypertrophic Cardiomyopathy
Session: Novel risk predictors in hypertrophic cardiomyopathy
